Profile data is unavailable for this security.
About the company
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
- Revenue in JPY (TTM)46.68bn
- Net income in JPY14.82bn
- Incorporated2006
- Employees621.00
- LocationPeptiDream Inc3-25-23, Tono-machi, Kawasaki-kuKAWASAKI-SHI 210-0821JapanJPN
- Phone+81 442701300
- Websitehttps://www.peptidream.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shin Nippon Biomedical Laboratories Ltd | 32.41bn | 4.92bn | 56.91bn | 1.44k | 11.56 | 1.42 | 7.61 | 1.76 | 118.30 | 118.30 | 778.58 | 961.35 | 0.3842 | 1.24 | 5.30 | 22,572,290.00 | 5.77 | 9.90 | 8.40 | 14.82 | 52.33 | 52.68 | 15.01 | 23.35 | 0.6946 | -- | 0.4633 | 30.49 | 22.55 | 17.36 | -10.96 | 14.07 | 54.79 | 58.49 |
| Healios KK | 588.00m | -4.37bn | 72.65bn | 65.00 | -- | 36.02 | -- | 123.55 | -46.81 | -46.81 | 6.42 | 19.27 | 0.0366 | -- | 2.63 | 9,046,154.00 | -27.16 | -24.31 | -43.03 | -30.77 | 73.30 | -- | -743.03 | -2,817.04 | -- | -1.59 | 0.7739 | -- | 362.81 | 44.46 | -10.78 | -- | 19.31 | -- |
| Heartseed Inc | 2.64bn | 614.54m | 75.49bn | 39.00 | 125.86 | 10.02 | 204.35 | 28.60 | 26.58 | 26.58 | 117.83 | 333.72 | 0.4047 | -- | 9.60 | 67,685,900.00 | 9.42 | -- | 9.89 | -- | -- | -- | 23.28 | -- | 19.27 | 157.48 | 0.0004 | -- | 153.42 | -- | 44.84 | -- | -- | -- |
| Takara Bio Inc | 45.04bn | 1.04bn | 99.58bn | 1.78k | 95.66 | 0.8622 | 18.48 | 2.21 | 8.65 | 8.65 | 374.03 | 959.19 | 0.3653 | 1.56 | 3.57 | 25,317,030.00 | 0.8816 | 8.66 | 0.9384 | 9.70 | 57.88 | 63.76 | 2.41 | 17.16 | 6.34 | -- | 0.0094 | 31.40 | 3.53 | 5.44 | -29.59 | -22.88 | 20.46 | 16.27 |
| SanBio Co Ltd | 0.00 | -4.27bn | 153.61bn | 29.00 | -- | 81.06 | -- | -- | -61.10 | -61.10 | 0.00 | 26.31 | 0.00 | -- | -- | 0.00 | -98.97 | -47.32 | -112.89 | -57.01 | -- | -- | -- | -- | -- | -4.45 | 0.4276 | -- | -- | -- | -9.02 | -- | -46.04 | -- |
| GNI Group Ltd | 22.98bn | -886.60m | 156.42bn | 867.00 | -- | 4.56 | -- | 6.81 | -17.71 | -17.71 | 458.85 | 679.05 | 0.3441 | 2.05 | 4.58 | 26,509,560.00 | -3.92 | 5.12 | -4.98 | 6.23 | 75.80 | 83.27 | -11.40 | 11.23 | 1.96 | -2.14 | 0.153 | 0.00 | -9.22 | 25.96 | -86.43 | 43.28 | 20.19 | -- |
| Peptidream Inc | 46.68bn | 14.82bn | 215.69bn | 621.00 | 14.53 | 3.91 | 12.69 | 4.62 | 114.17 | 114.17 | 360.07 | 424.19 | 0.6209 | 4.28 | 9.90 | 75,176,500.00 | 19.72 | 13.49 | 22.55 | 15.79 | 73.89 | 70.05 | 31.75 | 26.45 | 4.78 | 72.92 | 0.2574 | 0.00 | 62.57 | -- | 394.59 | -- | -- | -- |
Data as of Jul 18 2025. Currency figures normalised to PeptiDream Inc's reporting currency: Japanese Yen JPY
30.39%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| M&G Investment Management Ltd.as of 15 Apr 2025 | 11.05m | 8.50% |
| Asset Management One Co., Ltd.as of 13 Sep 2024 | 5.90m | 4.54% |
| Taiyo Pacific Partners LPas of 30 Jan 2025 | 5.07m | 3.90% |
| Baillie Gifford & Co.as of 30 Jun 2025 | 3.60m | 2.77% |
| Nomura Asset Management Co., Ltd.as of 03 Jul 2025 | 3.35m | 2.58% |
| The Vanguard Group, Inc.as of 02 Jul 2025 | 3.10m | 2.39% |
| Norges Bank Investment Managementas of 31 Dec 2024 | 2.55m | 1.96% |
| Nikko Asset Management Co., Ltd.as of 04 Jul 2025 | 1.77m | 1.36% |
| RBC Global Asset Management (Asia) Ltd.as of 31 Mar 2025 | 1.69m | 1.30% |
| Daiwa Asset Management Co. Ltd.as of 30 May 2025 | 1.44m | 1.11% |
More ▼
Data from 31 Dec 2024 - 02 Jul 2025Source: FactSet Research Systems Inc.
